Clinical features and management outcomes of hairy cell leukemia in routine clinical practice: a single center retrospective experience
Journal of Current Hematology & Oncology Research · 13.11.2026 · 4 (4) · 130-134
DOI: 10.51271/jchor-0096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Hematology & Oncology Research, online erschienen am 13.11.2026. Verfasst von Elif Suyanı und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
In this study, we aimed to review the clinical and treatment characteristics of hairy cell leukemai (HCL) patients.
Methods
This is a single-center retrospective study conducted at University of Health Sciences, Adana City Hospital, Hematology department between January 2018 and August 2025. The data of 33 patients with the diagnosis of hairy cell leukemia from the database of hospital records were analysed.
Results
First line treatment was cladribine in 27 (81.8%) patients, rituximab-cladribin in 2 (6.1 %) patients, interferon in 1 (3 %) patient and splenectomy in 3 (9.1 %) patients. Thirty one (93.9 %) patients responded to treatment and only 2 (6.1 %) did not. The progression was observed in 8 (25.8 %) of 31 responding patients. The probablity of progression free survival (PFS) at 10 years was 33 %. When the data is analysed according to the age groups of 60 y, the probability of PFS was 42.9 %, 83.3 %, 31.3 %,respectively (p=0.096). Also patients were grouped according to the age 60 y; and the probability of PFS at 10 years were 40.8% v.s 31.3% (p=0.034). All patients were alive at the end of follow up period, so median OS was not reached.
Conclusion
Cladribin was verified to be an effective treatment modality in HCL with high response rate, but low PFS. And the differences in the PFS according to age groups should be reevalated in the era of rituximab-cladribine combination and novel agents.
Zitieren
APA
Suyanı, E., Demirtaş, D., Aygün, B., Açık, D. Y., Karabulut, Z. T., Ünsal, Ç., & Büyükkurt, N. (2026). Clinical features and management outcomes of hairy cell leukemia in routine clinical practice: a single center retrospective experience. Journal of Current Hematology & Oncology Research, 4(4), 130-134. https://doi.org/10.51271/jchor-0096
Vancouver
Suyanı E, Demirtaş D, Aygün B, Açık DY, Karabulut ZT, Ünsal Ç, et al. Clinical features and management outcomes of hairy cell leukemia in routine clinical practice: a single center retrospective experience. Journal of Current Hematology & Oncology Research. 2026;4(4):130-134. doi:10.51271/jchor-0096
BibTeX
@article{Suyan2026,
author = {Suyanı, Elif and Demirtaş, Derya and Aygün, Bilal and Açık, Didar Yanardağ and Karabulut, Zeynep Tuğba and Ünsal, Çağatay and Büyükkurt, Nurhilal},
title = {Clinical features and management outcomes of hairy cell leukemia in routine clinical practice: a single center retrospective experience},
journal = {Journal of Current Hematology & Oncology Research},
year = {2026},
volume = {4},
number = {4},
pages = {130--134},
doi = {10.51271/jchor-0096}
}
EUVIMED